semaglutide mixed with tirzepatide Compounded GLP-1 - & Tirzepatide vs Semaglutide for Microdosing

Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)

Consider incorporating foods rich in biotin, iron, zinc, and vitamin D to support hair health

One practical advantage of tirzepatide: because the dose range is wider (2.5 to 15 mg vs 0.25 to 2.4 mg for semaglutide), there is more room for fine-tuning

Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I

Gender is an important determinant of CV risk within T2D [30]